Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Kroep

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|May 18, 2012
Advances in epithelial ovarian cancer therapyJ R Kroep
Cancer Treatment Reviews|September 30, 2017
CDK4/6 inhibition in early and metastatic breast cancer: A reviewA F de Groot, C J Kuijpers, J R Kroep
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR; in relation to enzyme activityJ Sigmond, W J Loves, J R Kroep, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 1999
Experimental drugs and drug combinations in pancreatic cancerJ R Kroep, H M Pinedo, C J van Groeningen, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2006
[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor]J R Kroep, H Gelderblom, A F S Collen, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 16, 2005
[Three patients with autoimmune hepatitis: the importance of early diagnosis and remission]J R Kroep, J H Bolk, A W E Weverling-Rijnsburger, et al.
Molecular Biology Reports|October 2, 2020
Chemotherapy resistance and stromal targets in breast cancer treatment: a reviewY M van der Spek, J R Kroep, R A E M Tollenaar, et al.
Cancer Treatment Reviews|November 21, 2017
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic reviewA F de Groot, N M Appelman-Dijkstra, S H van der Burg, et al.
Breast Cancer Research and Treatment|April 19, 2019
Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancerI Noordhoek, A F de Groot, D Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancerJ R Kroep, H M Pinedo, G Giaccone, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|May 18, 2012
Advances in epithelial ovarian cancer therapyJ R Kroep
Cancer Treatment Reviews|September 30, 2017
CDK4/6 inhibition in early and metastatic breast cancer: A reviewA F de Groot, C J Kuijpers, J R Kroep
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR; in relation to enzyme activityJ Sigmond, W J Loves, J R Kroep, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 1999
Experimental drugs and drug combinations in pancreatic cancerJ R Kroep, H M Pinedo, C J van Groeningen, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 13, 2006
[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor]J R Kroep, H Gelderblom, A F S Collen, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 16, 2005
[Three patients with autoimmune hepatitis: the importance of early diagnosis and remission]J R Kroep, J H Bolk, A W E Weverling-Rijnsburger, et al.
Molecular Biology Reports|October 2, 2020
Chemotherapy resistance and stromal targets in breast cancer treatment: a reviewY M van der Spek, J R Kroep, R A E M Tollenaar, et al.
Cancer Treatment Reviews|November 21, 2017
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic reviewA F de Groot, N M Appelman-Dijkstra, S H van der Burg, et al.
Breast Cancer Research and Treatment|April 19, 2019
Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancerI Noordhoek, A F de Groot, D Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancerJ R Kroep, H M Pinedo, G Giaccone, et al.
Pageof 7